SONUS PHARMACEUTICALS RAISES $17.8 MILLION IN PRIVATE PLACEMENT OF COMMON STOCK

Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS) today announced that it has closed the sale of approximately 4.65 million shares of its common stock at $3.77 per share, for net proceeds of approximately $16.8 million, in a private placement transaction with a group of institutional investors. For an additional $0.125 per underlying share, the investors also purchased five-year warrants to purchase approximately 2.33 million shares of common stock at an exercise price of $4.15 per share.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050816006026&newsLang=en)